Donald and Barbara Zucker School of Medicine Academic Works - Academic Competition and Research Symposium: Exceptional response to Cemiplimab in Cutaneous Squamous Cell Carcinoma
 

Exceptional response to Cemiplimab in Cutaneous Squamous Cell Carcinoma

Facility

Staten Island University Hospital

Department

Department of Medicine

Status

Resident

Category

Case Report

Start Date

2-6-2021 12:00 AM

This document is currently not available here.

Plum Print visual indicator of research metrics
PlumX Metrics
  • Usage
    • Abstract Views: 4
see details

Share

COinS
 
Jun 2nd, 12:00 AM

Exceptional response to Cemiplimab in Cutaneous Squamous Cell Carcinoma